Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
---|
06/03/2010 | US20100136011 Antibodies that bind to obm |
06/03/2010 | US20100135977 Compositions and methods for treating metabolic diseases |
06/03/2010 | US20100135963 Use of pax4 in pancreatic cell proliferation |
06/03/2010 | CA2748344A1 Enhanced bioactive formulations of resveratrol |
06/03/2010 | CA2745004A1 Pyridine-3-carboxyamide derivative |
06/03/2010 | CA2744828A1 Five crystal forms, methods of preparation, pharmaceutical compositions and applications of 3-(3'-carboxy-4'-hydroxy-anilino-carbo-)-6-nitro-7-hydroxy-8-methyl-coumarin)>> |
06/03/2010 | CA2744817A1 Bile acid recycling inhibitors for treatment of obesity and diabetes |
06/03/2010 | CA2744697A1 Use of compositions comprising bile acids, salts, and mimics thereof for treatment of obesity or diabetes |
06/03/2010 | CA2744178A1 Indole derivatives, method for preparing same and pharmaceutical compositions containing same |
06/03/2010 | CA2743241A1 6,7,8,9-tetrahydro-5h-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
06/02/2010 | EP2192120A1 Stable crystalline salt of 5-methyll-(6S)-tetrahydrofolic acid |
06/02/2010 | EP2192113A1 Novel crystal form XI of atorvastatin hemi-calcium and processes for its preparation |
06/02/2010 | EP2192112A1 Process for preparing atorvastatin hemi-calcium Form I |
06/02/2010 | EP2191849A1 Drug for suppressing pathogen occurring<i>in vivo</i> |
06/02/2010 | EP2191837A1 Blood sugar-modulating polypeptides |
06/02/2010 | EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone |
06/02/2010 | EP2191733A1 Nutrition containing fat blend |
06/02/2010 | EP2190842A1 Polymorph forms of (s)-2-((4-benzofuranyl)carbonylaminomethyl)-1-((4-(2-methyl-5-(4-fluorophenyl)thiazolyl)carbonyl)piperidine |
06/02/2010 | EP2190840A2 Chemical compounds 979 |
06/02/2010 | EP2190837A1 4-pyrimidinesulfamide derivative |
06/02/2010 | EP2190820A2 Substituted azepine- and diazepine-sulfonamides useful to inhibit 11beta-hydroxysteroid dehydrogenase type-1 |
06/02/2010 | EP2190464A2 Use of leptin(22-56) as a therapeutic agent |
06/02/2010 | EP2190463A2 Use of thymopentin as a therapeutic agent |
06/02/2010 | EP2190459A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent |
06/02/2010 | EP2190456A2 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer |
06/02/2010 | EP2190452A2 Use of a peptide as a therapeutic agent |
06/02/2010 | EP2190450A2 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents |
06/02/2010 | EP2190447A2 Use of stresscopin-related peptide as a therapeutic agent |
06/02/2010 | EP2029601B1 Pyridopyrimidinone derivatives |
06/02/2010 | EP1907386B1 Amino acid salts of rosiglitazone |
06/02/2010 | EP1558571B1 Novel compounds useful in treating ppar mediated diseases |
06/02/2010 | EP1553937B1 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv |
06/02/2010 | EP1541553B1 Indoline compound and medicinal use thereof |
06/02/2010 | EP1483228B1 Nk1 antagonists |
06/02/2010 | DE69224660C5 Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen Means for modulating process by retinoid receptors and for useful links |
06/02/2010 | CN1973662B Chinese herbal medicine type green concentrated feed for raising fattening pig |
06/02/2010 | CN1972698B Beta-hydroxy short to medium chain fatty acid polymer |
06/02/2010 | CN1938042B Use of aromatic cation peptide in preparing medicine for relieving oxidative damage |
06/02/2010 | CN1826336B Cyclohexanecarboxylic acid compound |
06/02/2010 | CN1659180B Novel recombinant anticoagulant proteins |
06/02/2010 | CN101720327A Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
06/02/2010 | CN101720319A Thiazolidine derivatives and methods for the preparation thereof |
06/02/2010 | CN101717442A Polyethylene glycol recombination DesB30 human insulin, preparation method and application thereof |
06/02/2010 | CN101717416A Derivative of alpha-amino phosphonic acid containing saccharide groups, preparation method and medical application thereof |
06/02/2010 | CN101717410A Phosphorus-containing compounds & uses thereof |
06/02/2010 | CN101717399A Compound with pyrazine and thiazolone structure and application thereof in preparing medicament for treating diabetes mellitus |
06/02/2010 | CN101717345A Threonine chromium compound and preparation method thereof |
06/02/2010 | CN101716347A Ruminant rumen-protected lysine and production method thereof |
06/02/2010 | CN101716332A Use of phycocyanin for preventing and treating diabetes mellitus |
06/02/2010 | CN101716302A Traditional Chinese medicine for treating diabetes mellitus |
06/02/2010 | CN101716297A Weight-reducing health-care tea |
06/02/2010 | CN101716294A Drop pill for treating diabetes mellitus |
06/02/2010 | CN101716293A Traditional Chinese medicine combination for treating diabetes mellitus |
06/02/2010 | CN101716290A Loach and finless eel fattening traditional Chinese medicine |
06/02/2010 | CN101716283A Method for constructing dendrobium officinale polysaccharide fingerprinting |
06/02/2010 | CN101716248A Traditional Chinese medicine composition for treating diabetes mellitus |
06/02/2010 | CN101716241A Weight-losing and fat-lowering medicinal composition and preparation method thereof |
06/02/2010 | CN101716229A Health-care tea for regulating blood sugar level and preparation method thereof |
06/02/2010 | CN101716213A Traditional Chinese medicine effective fraction composition for detoxification and lipid lowering and preparation method thereof |
06/02/2010 | CN101716206A Wild ginseng granules and preparation method thereof |
06/02/2010 | CN101716196A Cordycepin extractive and application thereof in preparing hypoglycemic drugs or health-care foods |
06/02/2010 | CN101716194A Multi-flavor chewable calcium tablets and production process thereof |
06/02/2010 | CN101716188A Animal pancreatic extract for preventing and curing diabetes |
06/02/2010 | CN101716182A combined medicine containing metformin hydrochloride and vitamin b12 |
06/02/2010 | CN101716181A Invert sugar medicament composition liposome injection and new application thereof |
06/02/2010 | CN101716180A Combined medicament for supplementing zinc and calcium and preparation method thereof |
06/02/2010 | CN101716166A Applications of 2', 4'-dihydroxyl-6'-methoxyl-3', 5'-dimethyl chalcone |
06/02/2010 | CN101716165A Use of oxyresveratrol |
06/02/2010 | CN101716154A Ursolic acid oral dispersant and preparation method thereof |
06/02/2010 | CN101585757B Method for preparing curcumin, demethoxycurcumin and bisdemethoxycurcumin |
06/02/2010 | CN101385718B Osmotic pump preparation composition for treating hyperlipemia |
06/02/2010 | CN101306010B Function food for reducing the blood sugar and preventing diabetes complicating disease |
06/02/2010 | CN101283982B Fenofibrate nanometer suspension and preparation method thereof |
06/02/2010 | CN101264331B New purpose of Chinese medicine almond |
06/02/2010 | CN101259278B Optimum matching multiple water-soluble vitamin medicinal composition containing high-efficiency bacteriostat and preparation thereof |
06/02/2010 | CN101259261B Diabetes treating traditional Chinese medicine |
06/02/2010 | CN101259101B Micrometre level arachidonic acid/docosahexaenoic acid emulsion and preparation thereof |
06/02/2010 | CN101244057B 3-substituted oxygen group-3',4'-dimethoxy flavonoid compound with blood fat reducing function |
06/02/2010 | CN101239046B Epalrestat dropping pills and preparation thereof |
06/02/2010 | CN101234106B Use of imidazolone compounds for treating cardiovascular and cerebrovascular diseases |
06/02/2010 | CN101230055B Lovastatin analogue as well as preparation method and uses thereof |
06/02/2010 | CN101214263B Method for preparing freeze-dried powder containing bacillus natto and nattokinase |
06/02/2010 | CN101204549B Composition of Chinese traditional medicine for diabetes mellitus |
06/02/2010 | CN101199540B Polygonin sheet and preparing method thereof |
06/02/2010 | CN101181545B Medicinal composition orally taken for treating diabetes |
06/02/2010 | CN101053621B Traditional Chinese medicinal composition for treating obesity and its preparation method |
06/02/2010 | CN101053592B Medicinal composition for treating impaired glucose tolerance and preparation method thereof |
06/02/2010 | CN101036714B Medicinal composition for treating and/or preventing diabetes |
06/02/2010 | CN101007771B Voglibose semi-hydrated crystal, its preparation method and its uses in medicament formulation |
06/01/2010 | US7728033 Mycophenolate mofetil in diabetic nephropathy |
06/01/2010 | US7728025 Glucokinase activators as antidiabetic, antiobesity agents; 5-(4-methanesulfonyl-phenoxy)-2-pyrazin-2-yl-6-(2-carbamoyl-phenoxy)-1H-benzimidazole for example |
06/01/2010 | US7728016 Substituted 5-membered ring compounds and their use |
06/01/2010 | US7727999 substituted 1,3,8-triaza-spiro[4.5]decan-2-one compounds, used as selective serotonin receptor antagonists, used rfor the treatment of schizophrenia, psychosis, headaches, hypertension, thrombosis, vasospasm, depression, anxiety, sleep disorders and appetite disorders |
06/01/2010 | US7727998 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
06/01/2010 | US7727977 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes |
06/01/2010 | US7727965 C-glycosylisoflavones having alkylaminoalkoxyl substituent, preparation and use of the same |
06/01/2010 | US7727964 Peptides substituted with a functional group that reacts with an active site residue of the targeted protease, e.g., Cyclohexylglycine BoroAla, and compounds that can hydrolyzed to produce them; improved specificity for regulating glucose metabolism |
06/01/2010 | CA2525867C Natural compounds and their derivatives for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
06/01/2010 | CA2515841C Novel 2-pyridine carboxamide derivatives |
06/01/2010 | CA2457965C Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives |